Discovery and validation of breast cancer subtypes

Kapp, Amy V; Jeffrey, Stefanie S; Langerod, Anita; Børresen-Dale, Anne-Lise; Han, Wonshik; Dong-Young Noh; Bukholm, Ida RK; Nicolau, Monica; Brown, Patrick O; Tibshirani, Robert
January 2007
BMC Genomics;2007, Vol. 8, p101
Academic Journal
Following the publication of our recent article (Kapp et al., BMC Genomics 2006, 7:231), we (the authors) regrettably found several errors in the published Table 5. This correction article not only describes what makes the published Table 5 incorrect, it also presents the correct Table 5.


Related Articles

  • Breast cancer genome heterogeneity: a challenge to personalised medicine? Swanton, Charles; Burrell, Rebecca A.; Andrew Futreal, P. // Breast Cancer Research;2012, Vol. 13 Issue 1, p1 

    Implementation of high-throughput genomics sequencing approaches into routine laboratory practice has raised the potential for the identification of multiple breast cancer targets suitable for future therapeutic intervention in order to improve cancer outcomes. Results from these studies have...

  • Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Easton, Douglas F. // Nature Genetics;May2009, Vol. 41 Issue 5, p585 

    Genome-wide association studies (GWAS) have identified seven breast cancer susceptibility loci, but these explain only a small fraction of the familial risk of the disease. Five of these loci were identified through a two-stage GWAS involving 390 familial cases and 364 controls in the first...

  • A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Thomas, Gilles; Jacobs, Kevin B.; Kraft, Peter; Yeager, Meredith; Wacholder, Sholom; Cox, David G.; Hankinson, Susan E.; Hutchinson, Amy; Zhaoming Wang; Kai Yu; Chatterjee, Nilanjan; Garcia-Closas, Montserrat; Gonzalez-Bosquet, Jesus; Prokunina-Olsson, Ludmila; Orr, Nick; Willett, Walter C.; Colditz, Graham A.; Ziegler, Regina G.; Berg, Christine D.; Buys, Saundra S. // Nature Genetics;May2009, Vol. 41 Issue 5, p579 

    We conducted a three-stage genome-wide association study (GWAS) of breast cancer in 9,770 cases and 10,799 controls in the Cancer Genetic Markers of Susceptibility (CGEMS) initiative. In stage 1, we genotyped 528,173 SNPs in 1,145 cases of invasive breast cancer and 1,142 controls. In stage 2,...

  • Systematic Bias in Genomic Classification Due to Contaminating Non-neoplastic Tissue in Breast Tumor Samples.  // BMC Medical Genomics;2011, Vol. 4 Issue 1, p54 

    The article offers information on the study conducted by the authors related to systematic bias in genomic classification in breast tissue samples due to contamination of non-neoplastic tissue. It states that 55 samples of breast cancer and normal tissues from the same patients were studied in...

  • Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Eirew, Peter; Steif, Adi; Khattra, Jaswinder; Ha, Gavin; Yap, Damian; Farahani, Hossein; Gelmon, Karen; Chia, Stephen; Mar, Colin; Wan, Adrian; Laks, Emma; Biele, Justina; Shumansky, Karey; Rosner, Jamie; McPherson, Andrew; Nielsen, Cydney; Roth, Andrew J. L.; Lefebvre, Calvin; Bashashati, Ali; de Souza, Camila // Nature;2/19/2015, Vol. 518 Issue 7539, p422 

    Human cancers, including breast cancers, comprise clones differing in mutation content. Clones evolve dynamically in space and time following principles of Darwinian evolution, underpinning important emergent features such as drug resistance and metastasis. Human breast cancer xenoengraftment is...

  • The Utility of Comparative Genetics to Inform Breast Cancer Prevention Strategies. Gould, Michael N. // Genetics;Oct2009, Vol. 183 Issue 2, p409 

    My research seeks to aid in developing approaches to prevent breast cancer. This research evolved from our early empirical studies for discovering natural compounds with anticancer activities, coupled with clinical evaluation to a genetics-driven approach to prevention. This centers on the use...

  • Genomics and breast cancer: the different levels of inherited susceptibility. Beggs, Andrew D.; Hodgson, Shirley V. // European Journal of Human Genetics;Jul2009, Vol. 17 Issue 7, p855 

    The article offers the authors opinion on an article published within the issue related to the different levels of inherited susceptibility in genomics and breast cancer. They say that there are many genes in which mutations can cause the risk of developing breast cancer. They inform that...

  • Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry. Scott, Cameron M.; Joo, JiHoon Eric; O’Callaghan, Neil; Buchanan, Daniel D.; Clendenning, Mark; Giles, Graham G.; Hopper, John L.; Wong, Ee Ming; Southey, Melissa C. // PLoS ONE;11/30/2016, Vol. 11 Issue 11, p1 

    DNA methylation can mimic the effects of both germline and somatic mutations for cancer predisposition genes such as BRCA1 and p16INK4a. Constitutional DNA methylation of the BRCA1 promoter has been well described and is associated with an increased risk of early-onset breast cancers that have...

  • Molecular and Functional Analysis of the SLIT2 Candidate Tumour Suppressor Gene in Breast Cancer.  // Journal of Medical Genetics;Sep2004 Supplement, Vol. 41, pS78 

    Presents an abstract of the study entitled "Molecular and Functional Analysis of the SLIT2 Candidate Tumour Suppressor Gene in Breast Cancer," by Rachel Dickinson, A. Dallol and F. Latif, presented during the British Human Genetics Conference held at the University of York in England from...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics